MICHAEL CAMPBELL: Open Payments
NPI 1376523621 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 31 payments from 13 companies in 2025. Trend: 2023 $529 · 2024 $624 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $210 |
| Novo Nordisk Inc | 8 | $135 |
| QOL Medical, LLC | 2 | $53 |
| Abbott Laboratories | 3 | $52 |
| PFIZER INC. | 2 | $51 |
| Lilly USA, LLC | 2 | $49 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Exact Sciences Corporation | 1 | $27 |
| ABBVIE INC. | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $23 |
Products named: BREZTRI, FARXIGA, Ozempic, Sucraid, FREESTYLE LIBRE 3, MOUNJARO, Wegovy, GARDASIL 9.
Industry payments across MA — which companies pay providers there.
